Xingjian Niu
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Pan-immune-inflammation value is a novel prognostic biomarker in pT2-4 gastric cancer.
Journal: Frontiers in medicine
Published: February 03, 2026
Harnessing the inflammatory signature: a review for biomarkers in inflammatory breast cancer.
Journal: QJM : monthly journal of the Association of Physicians
Published: July 25, 2025
Pan-immune-inflammation value predicts survival in inflammatory breast cancer patients.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: January 16, 2025
Identification and validation of hub genes in CD5-positive diffuse large B-cell lymphoma.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: February 27, 2023
Characteristics and survival analysis of breast cancer survivors with metachronous double primary cancers: a retrospective cohort study.
Journal: Translational cancer research
Published: December 20, 2022
Analyzing the multi-target pharmacological mechanism of folium Artemisia argyi acting on breast cancer: a network pharmacology approach.
Journal: Annals of translational medicine
Published: November 03, 2022
Serum amyloid A 1 induces suppressive neutrophils through the Toll-like receptor 2-mediated signaling pathway to promote progression of breast cancer.
Journal: Cancer science
Published: September 01, 2021
High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study.
Journal: BMC pharmacology & toxicology
Published: April 11, 2021
Enhancing Fatty Acid Catabolism of Macrophages Within Aberrant Breast Cancer Tumor Microenvironment Can Re-establish Antitumor Function.
Journal: Frontiers in cell and developmental biology
Published: February 09, 2021
Sodium/glucose cotransporter 1-dependent metabolic alterations induce tamoxifen resistance in breast cancer by promoting macrophage M2 polarization.
Journal: Cell death & disease
Published: December 27, 2020
HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer.
Journal: Cancer science
Published: October 12, 2020
Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters.
Journal: BMC cancer
Published: September 18, 2020
Last Updated: 09/26/2026